Science Portal
v2.1.6181.produswest2
Copyright © Médecins Sans Frontières
v2.1.6181.produswest2
Noma, also known as cancrum oris, is a rapidly progressing life-threatening infection that affects the mouth and face. Noma is preventable and easy to treat if addressed in the early reversible stages, but most often deadly if untreated. The disease most commonly affects children who are chronically malnourished or whose immune systems are otherwise compromised. Noma affects an estimated 140,000 children annually. Noma was added to the WHO's list of Neglected Tropical Diseases in 2023.
MSF is working to discover more about noma. This collection highlights MSF's mixed methods research on treatment outcomes, burden of disease, attitudes towards the disease and other aspects of noma.
For more information on MSF's work on noma, you can also visit https://noma.msf.org/.
Noma is a rapidly progressive orofacial gangrene that predominantly affects children living in extreme poverty. Despite its documentation since antiquity and its designation as a Worl...
INTRODUCTION
Noma is a rapidly progressing oral infection with a 90% mortality rate if untreated. Early identification by healthcare workers is critical, but li...
BACKGROUND
Noma is a gangrenous infection of the face that results in severe facial deformity, occurring primarily in malnourished and impoverished populations.
OBJ...
Noma (cancrum oris) is a rapidly progressing infection of the oral cavity, associated with a reported 90% mortality rate within weeks after the onset of first symptoms, if left untrea...